A detailed history of Brandywine Managers, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Brandywine Managers, LLC holds 18,338 shares of NTRA stock, worth $3.07 Million. This represents 2.52% of its overall portfolio holdings.

Number of Shares
18,338
Previous 17,444 5.12%
Holding current value
$3.07 Million
Previous $1.89 Million 23.35%
% of portfolio
2.52%
Previous 2.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$97.75 - $129.67 $87,388 - $115,924
894 Added 5.12%
18,338 $2.33 Million
Q4 2023

Feb 13, 2024

SELL
$37.55 - $62.64 $40,929 - $68,277
-1,090 Reduced 5.88%
17,444 $1.09 Million
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $130,200 - $187,560
-3,000 Reduced 13.93%
18,534 $820,000
Q1 2022

May 13, 2022

BUY
$30.32 - $91.33 $103,482 - $311,709
3,413 Added 18.83%
21,534 $876,000
Q1 2021

May 13, 2021

SELL
$91.47 - $124.36 $693,251 - $942,524
-7,579 Reduced 29.49%
18,121 $1.84 Million
Q1 2019

May 14, 2019

SELL
$11.34 - $20.62 $5,670 - $10,310
-500 Reduced 1.91%
25,700 $530,000
Q4 2018

Feb 12, 2019

BUY
$12.32 - $24.38 $36,960 - $73,140
3,000 Added 12.93%
26,200 $366,000
Q3 2018

Nov 14, 2018

BUY
$18.82 - $28.96 $1,882 - $2,896
100 Added 0.43%
23,200 $555,000
Q2 2018

Aug 10, 2018

SELL
$8.79 - $19.98 $24,611 - $55,944
-2,800 Reduced 10.81%
23,100 $435,000
Q1 2018

May 14, 2018

BUY
$9.0 - $11.95 $5,400 - $7,170
600 Added 2.37%
25,900 $240,000
Q4 2017

Feb 14, 2018

BUY
$8.99 - $14.31 $101,587 - $161,703
11,300 Added 80.71%
25,300 $227,000
Q3 2017

Nov 14, 2017

BUY
$8.02 - $13.33 $112,280 - $186,620
14,000
14,000 $180,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Brandywine Managers, LLC Portfolio

Follow Brandywine Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Managers, LLC with notifications on news.